NHS England's chair highlighted the Washwood Heath Health & Wellbeing Centre in Birmingham as a promising model for future community healthcare. The integrated approach, combining medical, social, and community services, aims to improve patient outcomes by addressing the holistic needs of the population and easing pressure on hospitals.

NHS England is set to introduce new regulations and associated guidance to ensure that modern slavery risks are identified and mitigated within NHS procurement processes, thereby reinforcing ethical supply chain practices and protecting labor rights.

NHS England, in collaboration with NHS Supply Chain Coordination Limited, conducted an extensive review covering 1,361 suppliers and 600,000 products to assess and mitigate modern slavery and human trafficking risks within its supply chains. The review, completed in December 2023, identified high-risk product areas including cotton-based items, surgical instruments, and PPE, and resulted in recommendations to embed robust due diligence and improved supplier management practices to protect vulnerable workers.

The Department of Health and Social Care published a review on modern slavery risks in NHS supply chains as part of a cross-government initiative. NHS England is set to work with the department and NHS Supply Chain to implement recommendations, including new procurement regulations and enhanced mapping of supply chains, to eradicate modern slavery and human trafficking risks in healthcare.

NHS England, in collaboration with NHS Supply Chain Coordination Ltd, conducted a comprehensive review to assess modern slavery and human trafficking risks across its supply chain. The review involved mapping high-risk products such as surgical instruments, gloves, gowns, uniforms, and face masks, while recommending enhanced due diligence measures and clearer supplier engagement protocols to protect vulnerable workers.

In November 2023, NHS England awarded Palantir a £330m contract to build a new data management platform, sparking controversy due to Palantir's ties to repressive surveillance technologies and its support for military operations in conflict zones, further exacerbated by protests from health workers in April 2024.

NHS England has awarded a £330m contract to US spy tech firm Palantir to develop a new data platform, a decision that has sparked concerns about patient privacy and potential surveillance risks.

NHS England has directed hundreds of hospitals to use Palantir Technologies’ Foundry software under the 'Faster Data Flows' initiative, mandating the sharing of patient data—including sensitive medical records—in a move that has raised serious privacy and ethical concerns, drawing criticism for lack of public consultation and parliamentary oversight.

In 2023, NHS England awarded a £330 million, seven‐year contract to Palantir Technologies to overhaul its IT infrastructure and develop the Federated Data Platform for managing patient data, raising concerns over surveillance risks, transparency issues, and increasing private dependency in public healthcare.

NHS England extended its contract with US surveillance firm Palantir to manage its Covid-19 datastore and other sensitive patient data. The move has drawn criticism over privacy, lack of public consent, and the use of technology linked to authoritarian practices given Palantir's connections to a billionaire Trump donor.

In 2023, NHS England and its associated bodies awarded multiple high-value contracts to the tech firm HorrOracle— including an over £8m contract for the UK Health Security Agency and another for integrating financial systems across 42 Integrated Care Boards. Critics argue that these procurement decisions risk embedding opaque technological solutions into public health infrastructure and may undermine accountability.